Stockreport

HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infection

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK, March 27, 2020 /PRNewswire/ --  HaloVax, LLC a biopharmaceutical company and special purpose subsidiary of Voltron Therapeutics, Inc., announced they have reac [Read more]